Evidence map›Paper›PMID 41445697›Full record

ArticleEuropean heart journal. Case reports2025

Long-term management of aortic stenosis (surgery and transcatheter options in young patients): a case report of valve-in-valve transcatheter aortic valve implantation.

Giulio Russo, Marcello Marchetta, Aris Moschovitis, Giuseppe Massimo Sangiorgi, Maurizio Taramasso

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giulio RussoDepartment of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, 00100 Rome, Italy.ORCID https://orcid.org/0000-0002-6302-0135
Marcello MarchettaDepartment of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, 00100 Rome, Italy.
Aris MoschovitisHerzZentrum Hirslanden, 8008 Zurich, Switzerland.
Giuseppe Massimo SangiorgiDepartment of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, 00100 Rome, Italy.ORCID https://orcid.org/0000-0001-5862-1967
Maurizio TaramassoHerzZentrum Hirslanden, 8008 Zurich, Switzerland.ORCID https://orcid.org/0000-0001-7295-1153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recent evidences have supported the use of transcatheter aortic valve implantation (TAVI) across all risk categories of patients. However, in case of young patients several points should be considered in a lifetime perspective taking into account both surgical and percutaneous therapies. Case summary: An 82-year-old man with a history of aortic valve disease treated 12 years earlier with surgical aortic valve and aortic root replacement was admitted for worsening dyspnoea. Echocardiogram showed degenerated surgical bioprosthesis with severe regurgitation. Due to prior surgery and high operative risk, the heart team opted for valve-in-valve TAVI. The procedure was successful and the patient remained asymptomatic at 30-day follow-up. Discussion: This case shows how to approach aortic valve disease in a lifetime perspective. Surgical and percutaneous approaches can be used in multiple combinations according to patient's age, anatomical characteristics and personal preferences.

Indexed as

Aortic regurgitationCase reportLifetime managementStructural valve deteriorationTranscatheter aortic valve implantationValve degenerationValve-in-valve

Identifiers

PMID41445697
PMCPMC12723482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.